Company / Operating Cash Flow per Share
AMICUS THERAPEUTICS, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.11
FY2025
5-year range
-$0.77 / $0.11
FY2021-FY2025
Trend
+196.0%
vs FY2024
Sector context
#70 of 212
Health Care
What the data says
At $0.11, AMICUS THERAPEUTICS, INC.'s operating cash flow per share ranks #70 of 212 in the Health Care sector. Operating Cash Flow per Share has increased for 7 consecutive years, from $-1.61 in FY2018 to $0.11 in FY2025.
Based on SEC 10-K filings.
0.11 in FY2025.
Improved from $-0.25 to $0.11 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#70 of 212 in Health CareTop 33% of 212This company $0.11 Sector average -$14.72
▼
+100.8% above sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s operating cash flow per share has grown for 7 consecutive years.
- In FY2025, operating cash flow per share increased 196.0% year-over-year.
- Ranks #70 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | +196.0% |
| FY2024 | -$0.12 | +53.0% |
| FY2023 | -$0.25 | +58.8% |
| FY2022 | -$0.60 | +22.7% |
| FY2021 | -$0.77 | +14.3% |
| FY2020 | -$0.90 | +13.5% |
| FY2019 | -$1.04 | +35.5% |
| FY2018 | -$1.61 | -7.8% |
| FY2017 | -$1.50 | -24.7% |
| FY2016 | -$1.20 | -14.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026